Notices. Notice

217 words·~1 min read·/register/2010/04/21/2010-9150

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

BILLING CODE 3710-08-P DEPARTMENT OF DEFENSE Department of the Army Availability for Non-Exclusive, Exclusive, or Partially Exclusive Licensing of U.S. Patent Application Concerning a Chimeric Ebola and Marburg Virus Glycoproteins Virus Like Particle Vaccine To Protect Against Diverse Ebola and Marburg Viruses AGENCY: Department of the Army, DoD. ACTION: Notice. SUMMARY: Announcement is made of the availability for licensing of the invention set forth in U.S. Patent Application Serial No. 61/338,967, entitled “A Chimeric Ebola and Marburg Virus Glycoproteins Virus Like Particle Vaccine To Protect Against Diverse Ebola and Marburg Viruses.

” The United States Government, as represented by the Secretary of the Army, has rights to this invention. ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, Frederick, MD 21702-5012. FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth Arwine, Patent Attorney,

(301)619-7808. For licensing issues, Dr. Paul Mele, Office of Research and Technology Applications (ORTA),

(301)619-6664, both at telefax

(301)619-5034. SUPPLEMENTARY INFORMATION: The invention relates to a chimeric Ebola and Marburg virus glycoproteins virus like particle vaccine and its use to protect against highly fatal diverse Ebola and Marburg viruses, in which no vaccine or proven countermeasure exists. Brenda S. Bowen, Army Federal Register Liaison Officer. [FR Doc. 2010-9150 Filed 4-20-10; 8:45 am]